亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體
Polyclonal Antibody to Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)
- 編號PAB934Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB934Mu01-亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 616 ¥ 1436 ¥ 2052 ¥ 5130 ¥ 20520
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
IHC圖
-
Figure. Western Blot; Sample: Recombinant LRG1, Mouse.
-
Western Blot; Sample: Lane1: Mouse Kidney lysate; Lane2: Mouse Lung lysate
Primary Ab: 0.15μg/ml Rabbit Anti-Mouse LRG1 Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對LRG1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別LRG1。
用法
Western blotting: 0.01-3μg/mL;
Immunohistochemistry: 5-30μg/mL;
Immunocytochemistry: 5-30μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB934Mu02 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu03 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu01 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB934Mu01 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB934Mu03 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB934Mu02 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| SEB934Mu | 亮氨酸豐富α2-糖蛋白1(LRG1)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB934Mu | 亮氨酸豐富α2-糖蛋白1(LRG1)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome [PubMed: 26351173] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study [pubmed:28112944] |
| OncoTargets?and Therapy | leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter [Pubmed:29785123] |
| PROTEOMICS?– Clinical Applications | Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset?… [Pubmed: 30411527] |
| Cancer Management and Research | iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia [Pubmed: 31440093] |
| J Clin Med | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children [Pubmed:35329889] |
留言咨詢
